Resumo

CASTELO ELIAS-CALLES, Lizet  e  GONZALEZ CALERO, Teresa Margarita. Dyslipemia and the HIV/AIDS. Rev Cubana Endocrinol [online]. 2010, vol.21, n.2, pp.202-222. ISSN 1561-2953.

The HIV epidemic is a public health problem at worldwide. The morbidity and mortality associated with AIDS have change in a significant way with the use of anti-retroviral therapy. However, it has been affected by the changes provoked in the lipoprotein metabolism, which are characterized by a rise of the very low-density lipoprotein (VLDL) levels and triglycerides, an increase of total cholesterol, low-density lipoprotein (LDL). HIV-infection associated with other inflammatory factors, is a progression model of atherosclerosis. The proatherogenic lipid profile in HIV/AIDS persons is a high risk for the development of the coronary disease. In present paper we analyzed the contribution of both the HIV-infection and the antiretroviral therapy effect on the lipid metabolism and its therapeutical procedure.

Palavras-chave : antiretroviral therapy; HIV/AIDS; dyslipemia; coronary risk.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )